A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients
Clinical trial NCT00246298 · TERMINATED
Trial details
- NCT number
- NCT00246298
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.